Whalesbook
Board Meeting Date Final!
So, Oxygenta Pharma ne announce kiya hai ki unka Board of Directors May 23, 2026 ko ek meeting karega. Is meeting mein FY26 ke liye jo March 31, 2026 ko khatam hua, uske final financial results officially approve kiye jayenge. Ismein fourth quarter ke numbers bhi shamil hain.
Pichhle Loss Ka Scene Aur Approval Ki Importance
Is approval ko sab log badi curiosity se dekh rahe hain. Reason ye hai ki company ka financial history thoda shaky raha hai. Ye results clear picture denge ki Oxygenta Pharma ne FY25-26 mein financially kaisa perform kiya hai.
FY23 Ka Haal Aur Past Ki Kahani
Yaad diladoon, FY23 mein company ka standalone revenue tha around ₹18.74 crore, aur net loss hua tha lagbhag ₹7.85 crore ka. Company pehle bhi badi financial difficulties se guzri hai, jaise loan default aur creditors dwara NCLT (National Company Law Tribunal) mein proceedings jo 2020-2022 ke aas paas hui thi. Yeh sab cheezein dikhati hain ki ye upcoming results company ki current financial stability ke liye kitne crucial hain.
Investors Kya Dekhenge?
Shareholders aur baaki sab stakeholders FY26 ke official results ka wait kar rahe hain. In numbers se pata chalega ki revenue, profitability aur overall financial health kaisi hai. Investors dekhenge ki kya company sustainable profit bana paa rahi hai aur financial management improve hua hai ya nahi. Pichhle financial problems ka impact bhi consider karna hoga, aur recovery ke liye consistent proof chahiye hoga.
Aage Kya?
Board meeting ke baad, sabse important hoga Q4 FY26 aur full FY26 results ka official disclosure. Auditor's report ke highlights aur management ka koi outlook bhi track karna hoga.